Napa Therapeutics

From H+Pedia
Jump to navigation Jump to search

Napa Therapeutics, Ltd is a biotech company researching ways to increase cellular levels of NAD+, a substance that depletes with age.[1][2] The company was created from a partnership between the Buck Institute and Juvenescence.[1]

References

  1. 1.0 1.1 "Napa Therapeutics, Ltd." Juvenescence. Retrieved 8 May 2021. "Napa Therapeutics, Ltd. is a discovery-stage company focused on NAD+ metabolism. There is ample evidence that NAD+ depletion is a key feature of aging. Napa’s core IP will surround a novel target within NAD+ metabolism to increase levels of NAD+ within the tissue. [...] Napa Therapeutics is a spinout from The Buck Institute for Research on Aging partnering with Juvenescence."
  2. "Napa Therapeutics". Longevity List. Retrieved 8 May 2021. "Drug that increases NAD+ levels"

External links